Cocrystal Pharma
COCP
28 hedge funds and large institutions have $754K invested in Cocrystal Pharma in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 1 closing their positions.
600% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 1
27% more funds holding
Funds holding: 22 → 28 (+6)
0.88% less ownership
Funds ownership: 6.47% → 5.59% (-0.88%)
9% less capital invested
Capital invested by funds: $831K → $754K (-$76.9K)
67% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
+$35.6K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$16K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$13.5K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.07K |
| 5 |
FFO
Fortitude Family Office
Scottsdale,
Arizona
|
+$3.41K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$11K |
| 2 |
Morgan Stanley
New York
|
-$5.2K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.33K |
| 4 |
Renaissance Technologies
New York
|
-$2.01K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$1.08K |
COCP Hedge Fund Activity: Q4 2025 in Review
28 of the 8,245 institutional investors tracked by Wall St. Rank reported a position in Cocrystal Pharma (COCP) for Q4 2025, worth a combined $754K — down 9.3% from $831K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new COCP positions and 1 closed out — a net gain of 6 holders — while 3 added to existing stakes and 9 trimmed.
The largest buyer was DRW Securities, opening a new position worth an estimated $35.6K. The largest seller was Jane Street, cutting an estimated $11K.
- 28 institutional investors held Cocrystal Pharma (COCP) as of Q4 2025, up from 22 in Q3 2025.
- Funds reported $754K of Cocrystal Pharma stock for Q4 2025, down 9.3% quarter-over-quarter.
- 7 funds opened new Cocrystal Pharma positions in Q4 2025 and 1 closed out, a net change of +6 holders.
- The largest Cocrystal Pharma buyer in Q4 2025 was DRW Securities, an estimated $35.6K added.
- The largest Cocrystal Pharma seller in Q4 2025 was Jane Street, an estimated $11K sold.
Based on aggregated 13F filings for Q4 2025.